Ortovox ProtACT 2,5L Civetta Hardshell Jacket Yellowstone Men
Product details: Ortovox ProtACT 2,5L Civetta Hardshell Jacket Yellowstone Men
The Ortovox ProtACT 2.5L Civetta is an ultra lightweight hardshell jacket for men who like to focuss on the essentials during alpine tours, without missing out on functionality and comfort. This jacket impresses with little weight (68 g/m²) and a highly functional Dermizax DT membrane by Toray.
A patented Micro Bead structure makes the inner membrane abrasion-resistant and increases the wearing comfort on your skin. Small beads are incorporated into the structure to support a quick moisture management. This makes for a dry feeling on your skin, thus, the fabric does not stick or feels wet.
Features like the elastic hem or the chest pocket make the Ortovox ProtACT 2.5L Civetta even more functional. The outdoor jacket can be completely stowed into its chest pocket. A small loop allows you to attach this small package to your climbing harness or to put it into your backpack without needing much space. This makes the lightweight ProtACT Civetta the perfect companion for alpine tours where little weight, small packing size and high protection are needed.
• Lightweight hardshell jacket for alpine tours
• Self-regulating hood with all-round elastic band and reinforced peak
• Breast pocket offers space for a map, topo, energy bar or smartphone
• Elastic cuffs and hem
• Merino Cool inserts
• Minimum pack size, stowable in the breast pocket
• Wind and waterproof
• Water column: min. 20,000 mm
• High breathability: min. 20,000 g/m² / 24 h
• Tested and recommended by VDBS
Outer material: 100 % polyamide
Membrane: 100 % polyurethane
Inserts: 85 % wool, 15 % polyamide
This product is part of the limited ProtACT collection and is made of high-quality leftover fabrics. This way, Ortovox tries to avoid textile waist, bring leftovers back into the cycle and give them a second life. ProtACT stands for Ortovox’ sustainable strategy which includes every area of the company and aims for beeing climate-neutral by 2024.